Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cellectis Regulatory Filings 2020

Sep 9, 2020

1190_ffr_2020-09-09_941750cb-81fa-4e82-a2e0-cc71d3cbd793.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

6-K/A 1 d22212d6ka.htm 6-K/A 6-K/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K/A

(Amendment No. 1 to Report on Form 6-K (Film No. 201078319))

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

Date of Report: September 9, 2020

Commission File Number: 001-36891

Cellectis S.A.

(Exact Name of registrant as specified in its charter)

8, rue de la Croix Jarry

75013 Paris, France

+33 1 81 69 16 00

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Explanatory Note

Cellectis S.A. (“Cellectis”) is amending its report on Form 6-K furnished to the Securities and Exchange Commission on August 5, 2020 (the “Original 6-K”) solely for the purpose of adding Exhibit 101, which contains Interactive Data File disclosure with respect to the unaudited interim consolidated financial statements included in the Original Form 6-K in accordance with Rule 405 of Regulation S-T. Except as described above, this amendment does not amend any information set forth in the Original 6-K and no changes have been made to the Original 6-K to reflect events occurring subsequent to August 5, 2020.

This report on Form 6-K/A shall be deemed to be incorporated by reference in the registration statements of Cellectis S.A. on Form F-3 (No. 333-238881) and Form S-8 (Nos. 333-204205, 333-214884, 333-222482 and 333-227717), to the extent not superseded by documents or reports subsequently filed.

Exhibits

Exhibit Title
101.INS XBRL Instance Document
101.SCH XBRL Taxonomy Extension Schema Document
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
101.LAB XBRL Taxonomy Extension Label Linkbase Document
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

/s/ André Choulika
André Choulika
Chief Executive Officer

3

EXHIBIT INDEX

Exhibit Title
99.1 Cellectis S.A.’s interim report for the six-month period ended June 30, 2020.

4